These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 5322265

  • 1. [Behavior of some hematochemical data and of the most important biological indexes of disease and of phase in subjects affected by pulmonary tuberculosis treated with morphazinamide].
    Caltagirone S.
    Minerva Med; 1965 Sep 01; 56(70):2766-71. PubMed ID: 5322265
    [No Abstract] [Full Text] [Related]

  • 2. [Action of morphazinamide in treatment of pulmonary tuberculosis].
    Sanguigno N, Carini A.
    Minerva Med; 1965 Sep 05; 56(71):2927-38. PubMed ID: 5322279
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of morphazinamide administered alone or in association in treatment of pulmonary tuberculosis. Observations on 126 treated cases].
    Longarato FJ.
    Minerva Med; 1965 Sep 05; 56(71):2954-61. PubMed ID: 5322284
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical research on the use of morphazinamide in pulmonary tuberculosis].
    Jancík E.
    Minerva Med; 1965 Sep 05; 56(71):2905-10. PubMed ID: 5322274
    [No Abstract] [Full Text] [Related]

  • 5. [The antitubercular activity of a pyrazinamide derivative: morphazinamide].
    Grassi C.
    Acta Tuberc Pneumol Belg; 1966 Sep 05; 57(3):196-210. PubMed ID: 4862621
    [No Abstract] [Full Text] [Related]

  • 6. [First results of monomedicamentous therapy with morphazinamide in pulmonary tuberculosis].
    Curatolo A, Sacerdoti C.
    Minerva Med; 1965 Sep 05; 56(71):2920-7. PubMed ID: 5322278
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
    Zierski M.
    Minerva Med; 1965 Sep 05; 56(71):2953-4. PubMed ID: 5322283
    [No Abstract] [Full Text] [Related]

  • 8. [Morphazinamide in the treatment of pulmonary tuberculosis].
    Alix Y Alix J, Camps Burón J, Domingo E, Daza M, García-Baquero JM, Lanzón J, Pignatelli F, Alix Trueba A.
    Rev Clin Esp; 1967 Dec 15; 107(5):347-54. PubMed ID: 5618870
    [No Abstract] [Full Text] [Related]

  • 9. [Morphazinamide and pulmonary tuberculosis (apropos of 112 cases)].
    Kallos S, Brouillet-Gabriel MT, Dumon JF.
    Rev Tuberc Pneumol (Paris); 1968 Dec 15; 32(3):432-6. PubMed ID: 5700028
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D, Siekierzyńska A, Styszewska H.
    Gruzlica; 1967 May 15; 35(5):453-63. PubMed ID: 6056260
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Morphazinamide in venous perfusions in the treatment of pulmonary tuberculosis].
    Alves de Souza M.
    Schweiz Med Wochenschr; 1966 Jun 25; 96(25):829-32. PubMed ID: 5987049
    [No Abstract] [Full Text] [Related]

  • 18. [Morphazinamide in association with other antimycobacterial drugs in the therapy of pulmonary tuberculosis].
    Moncalvo F, Moreo GG.
    Minerva Med; 1965 Sep 01; 56(70):2810-1. PubMed ID: 5852638
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.